| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G0ZDU4 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| B4DDM9 | cDNA FLJ50001, moderately similar to Kelch-like protein 17; | NULL | NULL | 163 | human |
| B4DUB6 | cDNA FLJ56851, highly similar to Zinc finger protein ZFP-36; | NULL | NULL | 610 | human |
| B3KSV6 | cDNA FLJ37141 fis, clone BRACE2023801, highly similar to AP-3 complex subunit delta-1; | NULL | NULL | 190 | human |
| B4E1U9 | cDNA FLJ54776, highly similar to Cell division control protein 42 homolog; | NULL | NULL | 236 | human |
| B4DPB8 | cDNA FLJ60759, highly similar to Cytochrome P450 4A11; EC 1.14.15.3; | NULL | NULL | 351 | human |
| B4E1C0 | cDNA FLJ54225, moderately similar to Bifunctional coenzyme A synthase; | NULL | NULL | 175 | human |
| B7Z1S8 | cDNA FLJ56059, highly similar to Engulfment and cell motility protein 2; | NULL | NULL | 537 | human |
| B4DVD2 | cDNA FLJ60170, highly similar to Guanine nucleotide-binding protein subunit beta 2-like 1; | NULL | NULL | 221 | human |
| B7SXT2 | Mutant opioid receptor mu; Fragment; | OPRM1; | NULL | 25 | human |
| B4DIC4 | cDNA FLJ52195, highly similar to LIM and SH3 domain protein 1; | NULL | NP_001258537.1; | 125 | human |
| G1EQD0 | MHC class I antigen; Fragment; | HLA-C; | NULL | 181 | human |
| B7Z1T3 | cDNA FLJ59186; | NULL | NULL | 189 | human |
| B4E3D4 | cDNA FLJ56293, highly similar to Transmembrane glycoprotein NMB; | NULL | NULL | 607 | human |
| B7Z7P7 | cDNA FLJ51397; | NULL | NULL | 303 | human |
| B6V6K6 | Mutant myocilin; | MYOC; | NULL | 504 | human |
| B7Z5L1 | cDNA FLJ51051, moderately similar to Abl interactor 2; | NULL | NULL | 326 | human |
| B7SEY4 | Dentin sialophosphoprotein; Fragment; | DSPP; | NULL | 814 | human |
| B7Z881 | cDNA FLJ52376, highly similar to Ras GTPase-activating-like protein IQGAP2; | NULL | NULL | 865 | human |
| B7Z2J6 | cDNA FLJ50504, highly similar to Mus musculus zinc finger, MYND domain containing 11 (Zmynd11), mRNA; | NULL | NP_001189395.1;XP_005252420.1; | 547 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |